Genesis Biopharma, Inc. to Host Investor Meetings in San Francisco in January 2012

LOS ANGELES--(BUSINESS WIRE)--Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, today announced that Anthony J. Cataldo, Chairman and Chief Executive Officer, and Martin Schroeder, a Company Director, will host investor meetings in San Francisco in conjunction with the JPMorgan 30th Annual Healthcare Conference, widely considered to be the largest healthcare-focused investment conference of the year.